Open access
55
Views
3
CrossRef citations to date
0
Altmetric
Original Research
Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease
Masakazu Ichinose1 Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, JapanCorrespondence[email protected]
, Ayako Takizawa2 Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan
, Toshiyasu Izumoto2 Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan
, Yusuke Tadayasu2 Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan
, Alan L Hamilton3 Boehringer Ingelheim, Burlington, Ontario, Canada
, Christina Kunz4 Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
& Yoshinosuke Fukuchi5 Juntendo University School of Medicine, Tokyo, Japan
show all
Pages 1673-1683
|
Published online: 20 Aug 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.